Peer-influenced content. Sources you trust. No registration required. This is HCN.

Hematology AdvisorAlgorithmic Approach to Identify Patients With Germline Predisposition Syndromes (GPS), Including Those With Hematologic Malignancies

Review Publication: Hematology Advisor
At the Annual Meeting of the Society of Hematologic Oncology, researchers presented a study identifying a higher percentage of patients with germline predisposition syndromes (GPS).
Results: Following a review of medical records of patients diagnosed with GPS between 1994 and 2018, the investigators reported that the detection of GPS positively impacted medical care in 91% of cases, including proper selection of a bone marrow donor, selection of drug and conditioning regimens, and genetic counseling.

The Healthcare Communications Network is owned and operated by IQVIA Inc.

Click below to leave this site and continue to IQVIA’s Privacy Choices form